{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+ketoconazole&page=2", "query": { "intervention": "Placebo ketoconazole", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 27, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+ketoconazole&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+ketoconazole&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-04T12:11:02.969Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02147964", "title": "ITT-5 Mechanisms of Spermatogenesis in Man", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Gonadotropin Deficiency" ], "interventions": [ { "name": "Testosterone 1% Gel", "type": "DRUG" }, { "name": "Acyline", "type": "DRUG" }, { "name": "Dutasteride", "type": "DRUG" }, { "name": "Ketoconazole", "type": "DRUG" }, { "name": "HCG", "type": "DRUG" }, { "name": "placebo dutasteride", "type": "DRUG" }, { "name": "placebo ketoconazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "MALE", "summary": "18 Years to 55 Years · Male only" }, "enrollment_count": 0, "start_date": "2019-06", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2019-12-18", "last_synced_at": "2026-10-04T12:11:02.969Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT02147964" }, { "nct_id": "NCT03142893", "title": "Hormonal Mechanisms of Sleep Restriction - Axis Study", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Sleep Restriction" ], "interventions": [ { "name": "Ketoconazole Pill", "type": "DRUG" }, { "name": "Ganirelix", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Dexamethasone Injection", "type": "DRUG" }, { "name": "Cosyntropin Injectable Product", "type": "DRUG" }, { "name": "Recombinant Human Luteinizing Hormone", "type": "DRUG" }, { "name": "Hydrocortisone Injection", "type": "DRUG" }, { "name": "Gonadorelin", "type": "DRUG" }, { "name": "Corticorelin", "type": "DRUG" }, { "name": "Placebo oral capsule", "type": "DRUG" }, { "name": "Saline Solution", "type": "DRUG" }, { "name": "Saline Solution for Injection", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Peter y. Liu", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "22 Years", "maximum_age": "45 Years", "sex": "MALE", "summary": "22 Years to 45 Years · Male only" }, "enrollment_count": 80, "start_date": "2017-05-08", "completion_date": "2026-06-30", "has_results": false, "last_update_posted_date": "2025-09-11", "last_synced_at": "2026-10-04T12:11:02.969Z", "location_count": 1, "location_summary": "Torrance, California", "locations": [ { "city": "Torrance", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03142893" }, { "nct_id": "NCT00302224", "title": "A Phase 1/2a Study of the 2S,4R Enantiomer of Ketoconazole in Subjects With Type 2 Diabetes Mellitus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Type 2 Diabetes" ], "interventions": [ { "name": "2S, 4R Ketoconazole (DIO-902)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "DiObex", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 50, "start_date": "2005-02", "completion_date": "2006-08", "has_results": false, "last_update_posted_date": "2008-02-22", "last_synced_at": "2026-10-04T12:11:02.969Z", "location_count": 5, "location_summary": "Washington D.C., District of Columbia • Omaha, Nebraska • Portland, Oregon + 2 more", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Omaha", "state": "Nebraska" }, { "city": "Portland", "state": "Oregon" }, { "city": "Dallas", "state": "Texas" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00302224" }, { "nct_id": "NCT00494663", "title": "A Phase 2b Study of DIO-902 or DIO-902 Placebo in Addition to Metformin and Atorvastatin or Atorvastatin Placebo for Type 2 Diabetes", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Type 2 Diabetes" ], "interventions": [ { "name": "DIO-902", "type": "DRUG" }, { "name": "DIO-902 placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "DiObex", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 200, "start_date": "2007-07", "completion_date": "2008-12", "has_results": false, "last_update_posted_date": "2008-11-13", "last_synced_at": "2026-10-04T12:11:02.969Z", "location_count": 12, "location_summary": "Muscle Shoals, Alabama • Tucson, Arizona • Jonesboro, Arkansas + 9 more", "locations": [ { "city": "Muscle Shoals", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Lakewood", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00494663" }, { "nct_id": "NCT06305637", "title": "A Study Comparing Ketoconazole Shampoo, 2% and Ketoconazole 2% Shampoo (RS) in the Treatment of Tinea Versicolor.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Tinea Versicolor" ], "interventions": [ { "name": "Ketoconazole Shampoo, 2%", "type": "DRUG" }, { "name": "Ketoconazole Shampoo, 2% (Reference Standard)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sun Pharmaceutical Industries, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 430, "start_date": "2023-12-04", "completion_date": "2024-02-10", "has_results": false, "last_update_posted_date": "2024-03-12", "last_synced_at": "2026-10-04T12:11:02.969Z", "location_count": 1, "location_summary": "Hawthorne, New York", "locations": [ { "city": "Hawthorne", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06305637" }, { "nct_id": "NCT00768690", "title": "A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of ABT-333", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "HCV Infection" ], "interventions": [ { "name": "ABT-333", "type": "DRUG" }, { "name": "ketoconazole", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Abbott", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 45, "start_date": "2008-10", "completion_date": null, "has_results": false, "last_update_posted_date": "2010-10-13", "last_synced_at": "2026-10-04T12:11:02.969Z", "location_count": 1, "location_summary": "Waukegan, Illinois", "locations": [ { "city": "Waukegan", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00768690" }, { "nct_id": "NCT01259115", "title": "Buprenorphine Accumulation and Description of Its Metabolites During Co-Medication of Buprenorphine Transdermal System (BTDS) and Ketoconazole", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Buprenorphine transdermal patch", "type": "DRUG" }, { "name": "Ketoconazole tablet", "type": "DRUG" }, { "name": "Placebo to match ketoconazole tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Purdue Pharma LP", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "54 Years", "sex": "ALL", "summary": "18 Years to 54 Years" }, "enrollment_count": 20, "start_date": "2002-10", "completion_date": "2003-06", "has_results": true, "last_update_posted_date": "2014-05-19", "last_synced_at": "2026-10-04T12:11:02.969Z", "location_count": 1, "location_summary": "New Orleans, Louisiana", "locations": [ { "city": "New Orleans", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT01259115" }, { "nct_id": "NCT00419783", "title": "A Randomized, Multiple Dose, Double Blind, 5-way Crossover Study of the Electrocardiographic (ECG) Effects of Bilastine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Bilastine", "type": "DRUG" }, { "name": "Bilastine & Ketoconazole", "type": "DRUG" }, { "name": "Moxifloxacin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Faes Farma, S.A.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 30, "start_date": "2006-08", "completion_date": "2006-12", "has_results": false, "last_update_posted_date": "2012-04-05", "last_synced_at": "2026-10-04T12:11:02.969Z", "location_count": 1, "location_summary": "Phoenix, Arizona", "locations": [ { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00419783" }, { "nct_id": "NCT04037605", "title": "Hormonal Mechanisms of Sleep Restriction - Axis Study in Older Men and Postmenopausal Women", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Sleep Restriction" ], "interventions": [ { "name": "Ketoconazole Pill (also known as nizoral)", "type": "DRUG" }, { "name": "Ganirelix", "type": "DRUG" }, { "name": "Dexamethasone Pill", "type": "DRUG" }, { "name": "Dexamethasone injection", "type": "DRUG" }, { "name": "Cosyntropin Injectable Product", "type": "DRUG" }, { "name": "Recombinant Human Luteinizing Hormone (also known as luveris)", "type": "DRUG" }, { "name": "Hydrocortisone Injection (also known as solu-cortef)", "type": "DRUG" }, { "name": "Gonadorelin (also known as Lutrepulse)", "type": "DRUG" }, { "name": "Corticorelin (also known as Acthrel)", "type": "DRUG" }, { "name": "Placebo oral tablet", "type": "DRUG" }, { "name": "Saline Solution", "type": "DRUG" }, { "name": "Saline solution for injection", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "60 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "60 Years to 80 Years" }, "enrollment_count": 5, "start_date": "2020-02-09", "completion_date": "2026-06-24", "has_results": false, "last_update_posted_date": "2025-09-11", "last_synced_at": "2026-10-04T12:11:02.969Z", "location_count": 1, "location_summary": "Torrance, California", "locations": [ { "city": "Torrance", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04037605" }, { "nct_id": "NCT00914121", "title": "Study Evaluating The Effect of Bosutinib (SKI-606) On Cardiac Repolarization (Rhythms Of The Heart)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Subjects" ], "interventions": [ { "name": "SKI-606", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Moxifloxacin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Wyeth is now a wholly owned subsidiary of Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 60, "start_date": "2009-06", "completion_date": "2009-08", "has_results": false, "last_update_posted_date": "2009-09-02", "last_synced_at": "2026-10-04T12:11:02.969Z", "location_count": 1, "location_summary": "Tacoma, Washington", "locations": [ { "city": "Tacoma", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00914121" } ] }